Skip to content

About Us
Royalty Portfolio
Opportunities
News
- Company & Partner News
- Press Releases
Investors
Contact

About Us
Royalty Portfolio
Opportunities
News
- Company & Partner News
- Press Releases
Investors
Contact

Governance Documents

Investors

Overview
News & Events
Financial Information
Stock Data
Analyst Coverage
SEC Filings
Governance

Governance Documents

Code of Ethics

Download Code of Ethics

Audit Committee Charter

Download Audit Committee Charter

Compensation Committee Charter

Download Compensation Committee Charter

Nominating and Governance Committee Charter

Download Nominating and Governance Committee Charter

Email Alerts
RSS News Feed

Terms of Use

© 2023 XOMA Corporation. All rights reserved.

All references to “portfolio” on this website refer strictly to milestone and/or royalty rights associated with a basket of drug products in development. All references to “assets” on this website refer strictly to milestone and/or royalty rights associated with individual drug product candidates in development. References to royalties or royalty rates strictly refer to future potential payment streams regardless of whether or not they are technically defined as royalties in the underlying contractual agreement; further, any rates referenced herein are subject to potential future contractual adjustments.

Follow us:

© 2023 XOMA • Powered by GeneratePress

Scroll back to top